Mitsubishi UFJ Asset Management Co. Ltd. Sells 28,192 Shares of Liquidia Corporation $LQDA

Mitsubishi UFJ Asset Management Co. Ltd. lessened its holdings in Liquidia Corporation (NASDAQ:LQDA) by 48.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,489 shares of the company’s stock after selling 28,192 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Liquidia were worth $957,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Federated Hermes Inc. purchased a new stake in Liquidia in the 3rd quarter valued at $7,290,000. Caprock Group LLC bought a new stake in Liquidia in the 3rd quarter worth about $37,114,000. Farallon Capital Management LLC increased its position in shares of Liquidia by 102.1% during the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock valued at $194,783,000 after acquiring an additional 4,326,876 shares during the last quarter. Apis Capital Advisors LLC purchased a new stake in shares of Liquidia during the 3rd quarter valued at $9,569,000. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in Liquidia during the third quarter worth about $2,026,000. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Liquidia News Roundup

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia delivered a major Q1 beat on both earnings and revenue, reinforcing confidence in its commercial momentum and profitability. Liquidia Corporation Reports First Quarter 2026 Financial Results
• Positive Sentiment: YUTREPIA sales continue to accelerate, with management targeting at least $1 billion in net revenue by 2027, which suggests a long runway for growth if launch momentum continues. Positive Sentiment
• Positive Sentiment: Needham and BTIG both raised price targets and maintained bullish ratings, signaling Wall Street sees more upside after the earnings release. Liquidia (NASDAQ:LQDA) Price Target Raised to $70.00 at Needham & Company LLC
• Neutral Sentiment: CEO Roger Jeffs sold 25,000 shares under a pre-arranged 10b5-1 plan; the transaction is small relative to his remaining stake, but it may still draw some investor attention. SEC filing
• Negative Sentiment: One recent note argued that YUTREPIA’s launch upside may be getting closer to a ceiling, suggesting the market could eventually question how much more share growth is available. Liquidia: Yutrepia’s Launch Momentum Is Approaching A Ceiling (Rating Downgrade)

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on LQDA. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. HC Wainwright upped their target price on shares of Liquidia from $55.00 to $67.00 and gave the stock a “buy” rating in a report on Tuesday. Wells Fargo & Company raised their price target on Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a report on Tuesday. Jefferies Financial Group reissued a “buy” rating and set a $60.00 price objective on shares of Liquidia in a report on Monday. Finally, BTIG Research upped their price objective on shares of Liquidia from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Monday. Three investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $49.33.

Liquidia Stock Up 6.5%

Shares of NASDAQ:LQDA opened at $56.60 on Wednesday. The stock’s 50-day moving average is $38.17 and its 200 day moving average is $35.29. The company has a market cap of $5.03 billion, a PE ratio of 404.31 and a beta of 0.41. The company has a debt-to-equity ratio of 2.97, a current ratio of 2.01 and a quick ratio of 1.84. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $57.00.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 81.61%. The company had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia’s revenue was up 4187.1% on a year-over-year basis. Sell-side analysts anticipate that Liquidia Corporation will post 2.14 EPS for the current year.

Insider Activity

In other Liquidia news, CFO Michael Kaseta sold 139,390 shares of Liquidia stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $40.14, for a total value of $5,595,114.60. Following the completion of the transaction, the chief financial officer directly owned 353,356 shares of the company’s stock, valued at approximately $14,183,709.84. The trade was a 28.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Roger Jeffs sold 32,744 shares of the company’s stock in a transaction that occurred on Monday, April 13th. The shares were sold at an average price of $38.37, for a total value of $1,256,387.28. Following the completion of the transaction, the chief executive officer directly owned 1,137,599 shares in the company, valued at $43,649,673.63. This trade represents a 2.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 653,820 shares of company stock worth $25,838,508. Insiders own 25.60% of the company’s stock.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).